SI1921144T1 - Postopek za vezavo sekvenc ki nas zanimajo - Google Patents

Postopek za vezavo sekvenc ki nas zanimajo

Info

Publication number
SI1921144T1
SI1921144T1 SI200431823T SI200431823T SI1921144T1 SI 1921144 T1 SI1921144 T1 SI 1921144T1 SI 200431823 T SI200431823 T SI 200431823T SI 200431823 T SI200431823 T SI 200431823T SI 1921144 T1 SI1921144 T1 SI 1921144T1
Authority
SI
Slovenia
Prior art keywords
extension
variable region
pcr
cell receptors
interest
Prior art date
Application number
SI200431823T
Other languages
English (en)
Inventor
Martin B Oleksiewicz
Lars S Nielsen
Peter S Andersen
Margit H Hansen
Original Assignee
Symphogen As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44209637&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1921144(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Symphogen As filed Critical Symphogen As
Publication of SI1921144T1 publication Critical patent/SI1921144T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/005Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1093General methods of preparing gene libraries, not provided for in other subgroups
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C40B40/08Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55Fab or Fab'
SI200431823T 2003-09-18 2004-09-17 Postopek za vezavo sekvenc ki nas zanimajo SI1921144T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US50445503P 2003-09-18 2003-09-18
US50458903P 2003-09-18 2003-09-18
DKPA200301867 2003-12-17
DKPA200400782 2004-05-15

Publications (1)

Publication Number Publication Date
SI1921144T1 true SI1921144T1 (sl) 2012-03-30

Family

ID=44209637

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200431823T SI1921144T1 (sl) 2003-09-18 2004-09-17 Postopek za vezavo sekvenc ki nas zanimajo
SI200430728T SI1670912T1 (sl) 2003-09-18 2004-09-17 Metoda za povezovanje ĺ˝elenih zaporedij

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200430728T SI1670912T1 (sl) 2003-09-18 2004-09-17 Metoda za povezovanje ĺ˝elenih zaporedij

Country Status (18)

Country Link
US (2) US7749697B2 (sl)
EP (3) EP1516929A3 (sl)
JP (1) JP4651619B2 (sl)
CN (2) CN102199593A (sl)
AT (2) ATE537256T1 (sl)
AU (1) AU2004286019B2 (sl)
BR (1) BRPI0414282A (sl)
CA (1) CA2539576A1 (sl)
DE (1) DE602004012299T2 (sl)
DK (2) DK1670912T3 (sl)
ES (2) ES2375529T3 (sl)
MY (1) MY148907A (sl)
NZ (1) NZ545936A (sl)
PL (2) PL1921144T3 (sl)
PT (2) PT1921144E (sl)
SI (2) SI1921144T1 (sl)
TW (1) TWI333977B (sl)
WO (1) WO2005042774A2 (sl)

Families Citing this family (121)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1583830E (pt) * 2003-01-07 2006-11-30 Symphogen As Método para produzir proteínas policlonais recombinantes
ATE474915T1 (de) * 2003-11-19 2010-08-15 Us Gov Health & Human Serv Verfahren zur induktion der entwicklung und terminalen differenzierung von gedächtnis-b- zellen
KR101319848B1 (ko) 2004-07-20 2013-10-18 심포젠 에이/에스 재조합 폴리클로날 단백질 또는 폴리클로날 세포주의구조적 특성화 방법
AU2005263331B8 (en) * 2004-07-20 2011-06-16 Symphogen A/S Anti-Rhesus D recombinant polyclonal antibody and methods of manufacture
EP2322622A3 (en) 2005-03-25 2012-03-07 National Research Council of Canada Method for isolation of soluble polypeptides
EP1707628B1 (en) * 2005-03-30 2009-11-11 Sekisui Chemical Co., Ltd. Methods for producing recombinant polyclonal immunoglobulins
US8945857B2 (en) 2005-07-01 2015-02-03 John Schrader Methods of isolating cells and generating monoclonal antibodies
US7850965B2 (en) 2005-12-05 2010-12-14 Symphogen A/S Anti-orthopoxvirus recombinant polyclonal antibody
WO2007101441A1 (en) * 2006-03-06 2007-09-13 Symphogen A/S Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
US7504106B2 (en) 2006-03-14 2009-03-17 Boris Skurkovich Method and composition for treatment of renal failure with antibodies and their equivalents as partial or complete replacement for dialysis
NZ578851A (en) * 2007-03-01 2011-09-30 Symphogen As Method for cloning cognate antibodies
ES2582386T3 (es) * 2007-03-01 2016-09-12 Symphogen A/S Composiciones de anticuerpos recombinantes contra el receptor del factor de crecimiento epidérmico
EP2134747A2 (en) * 2007-03-06 2009-12-23 Symphogen A/S Recombinant antibodies for treatment of respiratory syncytial virus infections
JP5941616B2 (ja) 2007-05-25 2016-06-29 シムフォゲン・アクティーゼルスカブSymphogen A/S 組み換えポリクローナルタンパク質を製造する方法
JP2008289483A (ja) * 2007-05-25 2008-12-04 Symphogen As 真核生物系において発現可能な形質転換体のスクリーニング
WO2009030237A2 (en) * 2007-09-07 2009-03-12 Symphogen A/S Methods for recombinant manufacturing of anti-rsv antibodies
US8268564B2 (en) * 2007-09-26 2012-09-18 President And Fellows Of Harvard College Methods and applications for stitched DNA barcodes
US7792057B2 (en) * 2007-12-21 2010-09-07 At&T Labs, Inc. Method and system for computing multicast traffic matrices
WO2010000864A1 (en) * 2008-07-04 2010-01-07 Novo Nordisk A/S Method for producing monoclonal antibodies
CN102137874B (zh) 2008-08-29 2015-02-18 西福根有限公司 抗表皮生长因子受体的重组抗体组合物
BRPI0917352A2 (pt) * 2008-08-29 2017-08-22 Symphogen As Métodos para produção de uma biblioteca de pares cognatos que compreende sequências ligadas que codificam regiões variáveis e para gerar um vetor que codifica um anticorpo quimérico com regiões de seres humanos constantes e regiões variáveis não humanas, biblioteca de vetores, e método para produção de uma biblioteca de sequências de imunoglobulina derivadas de aves
CN102265152A (zh) * 2008-10-06 2011-11-30 西福根有限公司 鉴定和选择用于组合药品的药物候选物
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
US8748103B2 (en) 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
EP2719774B8 (en) 2008-11-07 2020-04-22 Adaptive Biotechnologies Corporation Methods of monitoring conditions by sequence analysis
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US8691510B2 (en) 2008-11-07 2014-04-08 Sequenta, Inc. Sequence analysis of complex amplicons
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
DK3059337T3 (da) 2009-01-15 2019-07-22 Adaptive Biotechnologies Corp Adaptive immunity profiling og metoder til frembringelse af monoklonale antibodier
EP2401294B1 (en) * 2009-02-25 2018-09-05 UCB Biopharma SPRL Method for producing antibodies
GB0903207D0 (en) 2009-02-25 2009-04-08 Ucb Pharma Sa Method for expressing multimeric proteins
US8563305B2 (en) 2009-04-30 2013-10-22 Oklahoma Medical Research Foundation Rapid generation of antibodies
CN102449149B (zh) 2009-05-29 2014-04-23 莫佛塞斯公司 集合及其使用方法
KR20120044941A (ko) 2009-06-25 2012-05-08 프레드 헛친슨 켄서 리서치 센터 적응 면역의 측정방법
US9043160B1 (en) 2009-11-09 2015-05-26 Sequenta, Inc. Method of determining clonotypes and clonotype profiles
JP2013521759A (ja) * 2010-02-18 2013-06-13 Meiji Seikaファルマ株式会社 緑膿菌の血清型b型リポ多糖に対する抗体
US10392726B2 (en) 2010-10-08 2019-08-27 President And Fellows Of Harvard College High-throughput immune sequencing
EA201390472A1 (ru) 2010-10-29 2014-02-28 Иммьюноджен, Инк. Новые молекулы, связывающиеся с egfr, и их иммуноконъюгаты
AU2011320318B9 (en) * 2010-10-29 2015-11-19 Immunogen, Inc. Non-antagonistic EGFR-binding molecules and immunoconjugates thereof
US9155802B2 (en) 2010-11-01 2015-10-13 Symphogen A/S Pan-HER antibody composition
WO2012059858A1 (en) 2010-11-01 2012-05-10 Symphogen A/S Anti-her3 antibodies and compositions
EP2640743B1 (en) 2010-11-16 2016-10-05 Excelimmune, Inc. Methods for producing recombinant proteins
JP6253986B2 (ja) 2010-11-19 2017-12-27 モルフォシス・アーゲー コレクション及びその使用方法
KR20140027915A (ko) * 2010-12-01 2014-03-07 모르포시스 아게 단일 세포 내 생체 분자의 동시 검출
DK2652155T3 (en) 2010-12-16 2017-02-13 Gigagen Inc Methods for Massive Parallel Analysis of Nucleic Acids in Single Cells
AU2011352207B2 (en) * 2010-12-31 2016-03-03 Bioatla, Llc Comprehensive monoclonal antibody generation
US20130316358A1 (en) * 2011-01-31 2013-11-28 Yeda Research And Development Co. Ltd. Methods of diagnosing disease using overlap extension pcr
PT2702146T (pt) 2011-04-28 2019-04-22 Univ Leland Stanford Junior Identificação de polinucleótidos associados a uma amostra
US20230287392A1 (en) * 2011-04-28 2023-09-14 The Board Of Trustees Of The Leland Stanford Junior University Identification of Polynucleotides Associated with a Sample
WO2012174214A1 (en) 2011-06-15 2012-12-20 The Regents Of The University Of California High resolution analysis of mammalian transcriptome using gene pool specific primers
RU2636045C2 (ru) 2011-07-12 2017-11-17 ИксБиотеч, Инк. Выявление аффинно-зрелых человеческих антител
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
US9279159B2 (en) 2011-10-21 2016-03-08 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
CA2856411A1 (en) 2011-11-21 2013-05-30 Immunogen, Inc. Method of treatment of tumors that are resistant to egfr therapies by egfr antibody cytotoxic agent conjugate
EP3904536A1 (en) 2011-12-09 2021-11-03 Adaptive Biotechnologies Corporation Diagnosis of lymphoid malignancies and minimal residual disease detection
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
EP2626433B1 (en) * 2012-02-09 2017-04-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for linking nucleic acids in a microsome from endoplasmatic reticuli
EP2823060B1 (en) 2012-03-05 2018-02-14 Adaptive Biotechnologies Corporation Determining paired immune receptor chains from frequency matched subunits
EP2844675B1 (en) 2012-05-02 2019-01-02 Symphogen A/S Humanized pan-her antibody compositions
JP5756247B1 (ja) 2012-05-08 2015-07-29 アダプティブ バイオテクノロジーズ コーポレイション マルチプレックスpcr反応における増幅バイアスを測定し校正する組成物及び方法
WO2013188772A1 (en) * 2012-06-14 2013-12-19 Gigagen, Inc. Methods for antibody and cell therapeutic discovery
CA2875695C (en) 2012-06-15 2022-11-15 The Board Of Regents Of The University Of Texas System High throughput sequencing of multiple transcripts of a single cell
EP2904111B1 (en) 2012-10-01 2017-12-06 Adaptive Biotechnologies Corporation Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
US10150996B2 (en) 2012-10-19 2018-12-11 Adaptive Biotechnologies Corp. Quantification of adaptive immune cell genomes in a complex mixture of cells
CA2898197C (en) 2013-01-24 2019-07-09 Scripps Korea Antibody Institute Protein combination-based fv library, and preparation method therefor
EP2953970A4 (en) 2013-02-08 2016-06-29 Misfolding Diagnostics Inc TRANSTYRETIN ANTIBODIES AND USES THEREOF
AU2014233145A1 (en) 2013-03-15 2015-09-17 Theranos Ip Company, Llc Nucleic acid amplification
US10450595B2 (en) 2013-03-15 2019-10-22 Theranos Ip Company, Llc Nucleic acid amplification
MX365323B (es) 2013-03-15 2019-05-29 Theranos Ip Co Llc Amplificación de ácidos nucléicos.
WO2014145298A1 (en) 2013-03-15 2014-09-18 Theranos, Inc. Nucleic acid amplification
US9816088B2 (en) 2013-03-15 2017-11-14 Abvitro Llc Single cell bar-coding for antibody discovery
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
EP3042208A4 (en) 2013-09-06 2017-04-19 Theranos, Inc. Systems and methods for detecting infectious diseases
GB201316644D0 (en) 2013-09-19 2013-11-06 Kymab Ltd Expression vector production & High-Throughput cell screening
CN103820430A (zh) * 2013-12-19 2014-05-28 河南科技大学 高gc含量或以复杂结构dna为模板的dna片段的重叠延伸pcr法
KR102433825B1 (ko) 2013-12-30 2022-08-31 아트레카, 인크. 핵산 바코드를 이용하는 단일 세포와 관련된 핵산의 분석
WO2015120403A1 (en) * 2014-02-08 2015-08-13 The Regents Of The University Of Colorado, A Body Corporate Multiplexed linking pcr
GB201402591D0 (en) * 2014-02-14 2014-04-02 Memo Therapeutics Ag Method for recovering two or more genes, or gene products, encoding an immunoreceptor
WO2015134787A2 (en) 2014-03-05 2015-09-11 Adaptive Biotechnologies Corporation Methods using randomer-containing synthetic molecules
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
WO2015182749A1 (ja) * 2014-05-30 2015-12-03 国立大学法人富山大学 TCR cDNAの増幅方法
EP3194593B1 (en) 2014-09-15 2019-02-06 AbVitro LLC High-throughput nucleotide library sequencing
IL250902B (en) 2014-09-16 2022-08-01 Symphogen As Anti-met antibodies and preparations
WO2016069886A1 (en) * 2014-10-29 2016-05-06 Adaptive Biotechnologies Corporation Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
EP3498866A1 (en) 2014-11-25 2019-06-19 Adaptive Biotechnologies Corp. Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
CN104560980B (zh) * 2015-01-20 2017-04-05 中国人民解放军第三军医大学 基于高通量测序构建鼠BCR轻链Lamda文库的多重PCR引物和方法
WO2016138122A1 (en) 2015-02-24 2016-09-01 Adaptive Biotechnologies Corp. Methods for diagnosing infectious disease and determining hla status using immune repertoire sequencing
US10513733B2 (en) 2015-03-23 2019-12-24 Board Of Regents, The University Of Texas System High throughout sequencing of paired VH and VL transcripts from B cells secreting antigen-specific antibodies
AU2016242967B2 (en) 2015-04-01 2021-07-01 Adaptive Biotechnologies Corp. Method of identifying human compatible T cell receptors specific for an antigenic target
EP4345107A2 (en) 2015-06-09 2024-04-03 Gigagen, Inc. Recombinant fusion proteins and libraries from immune cell repertoires
US9422547B1 (en) 2015-06-09 2016-08-23 Gigagen, Inc. Recombinant fusion proteins and libraries from immune cell repertoires
WO2017024173A1 (en) 2015-08-04 2017-02-09 The Regents Of The University Of Colorado Multiplexed binary assembly and quantitative tracking of bacterial populations
CN105087560B (zh) * 2015-08-07 2016-06-01 深圳市瀚海基因生物科技有限公司 一种基于高通量测序构建猪bcr重链文库的多重pcr引物和方法
SI3368572T1 (sl) 2015-10-02 2022-10-28 Symphogen A/S Protitelesa proti PD-1 in sestavki
WO2017096239A1 (en) * 2015-12-04 2017-06-08 St. Jude Children's Research Hospital, Inc. Cloning and expression system for t-cell receptors
EP3277810B8 (en) * 2016-01-08 2020-07-15 Maxion Therapeutics Limited Binding members with altered diversity scaffold domains
WO2017180738A1 (en) * 2016-04-12 2017-10-19 Medimmune, Llc Immune repertoire mining
AU2017326338A1 (en) 2016-09-15 2019-01-31 Augmenta Bioworks, Inc. Immune repertoire sequence amplification methods and applications
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
JP7178999B2 (ja) 2016-11-18 2022-11-28 シムフォゲン・アクティーゼルスカブ 抗pd-1抗体および組成物
WO2018102473A2 (en) * 2016-11-29 2018-06-07 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods and materials for cloning functional t cell receptors from single t cells
CN110366557B (zh) * 2016-12-23 2024-04-09 威特拉公司 结合多肽及其制备方法
KR102137722B1 (ko) 2017-03-13 2020-07-28 기가젠, 인코포레이티드 단일 세포들의 초병렬 조합 분석을 위한 시스템들 및 방법들
WO2019061198A1 (zh) * 2017-09-28 2019-04-04 深圳华大生命科学研究院 一种扩增tcr全长序列的试剂盒及其应用
WO2019061197A1 (zh) * 2017-09-28 2019-04-04 深圳华大生命科学研究院 一种扩增tcr全长序列的pcr引物及其应用
WO2019084538A1 (en) 2017-10-27 2019-05-02 Board Of Regents, The University Of Texas System TUMOR SPECIFIC ANTIBODIES, T CELL RECEPTORS AND METHODS OF IDENTIFICATION THEREOF
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
KR102543325B1 (ko) 2018-08-13 2023-06-13 루트패스 제노믹스, 인크. 쌍을 이룬 이분 면역수용체 폴리뉴클레오티드의 고처리량 클로닝 및 이의 적용
US11662341B2 (en) 2018-10-10 2023-05-30 Augmenta Bioworks, Inc. Methods for isolating immune binding proteins
CN109972209B (zh) * 2019-01-18 2022-05-03 南开大学 基于乳液pcr的一步法将单链抗体库重排为全长抗体库的方法
WO2020191365A1 (en) 2019-03-21 2020-09-24 Gigamune, Inc. Engineered cells expressing anti-viral t cell receptors and methods of use thereof
WO2020206238A2 (en) 2019-04-05 2020-10-08 Rootpath Genomics, Inc. Compositions and methods for t-cell receptor gene assembly
KR20220003055A (ko) * 2019-04-30 2022-01-07 기가젠, 인코포레이티드 재조합 폴리클로날 단백질 및 이의 사용 방법
CN111139286B (zh) * 2019-11-07 2023-11-21 南方医科大学南方医院 一种bcr高通量测序文库的构建方法
CA3177152A1 (en) 2020-06-12 2021-12-16 David Scott Johnson Recombinant polyclonal proteins targeting covid-19 and methods of use thereof
WO2022031834A1 (en) 2020-08-05 2022-02-10 Gigagen, Inc. Recombinant polyclonal proteins targeting zika and methods of use thereof
CN114774405A (zh) * 2022-04-19 2022-07-22 上海赛唐生物技术有限公司 一种单链抗体扩展库的制备方法及其应用
WO2023213787A1 (en) 2022-05-02 2023-11-09 Aarhus Universitet Antibodies for prophylaxis or treatment of sars- cov-2 infections
WO2024050450A1 (en) 2022-08-31 2024-03-07 Gigamune, Inc. Engineered enveloped vectors and methods of use thereof

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5618920A (en) 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
US5576195A (en) 1985-11-01 1996-11-19 Xoma Corporation Vectors with pectate lyase signal sequence
US5906936A (en) 1988-05-04 1999-05-25 Yeda Research And Development Co. Ltd. Endowing lymphocytes with antibody specificity
DE4010839A1 (de) * 1990-04-04 1991-10-10 Bosch Gmbh Robert Vorrichtung zur erzeugung eines triggersignals aus zuendimpulsen einer zuendanlage
AU1457992A (en) * 1991-03-01 1992-10-06 Stratagene Pcr generated dicistronic dna molecules for producing antibodies
US6277969B1 (en) 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US6284471B1 (en) 1991-03-18 2001-09-04 New York University Medical Center Anti-TNFa antibodies and assays employing anti-TNFa antibodies
JPH06509473A (ja) * 1991-08-10 1994-10-27 メディカル・リサーチ・カウンシル 細胞個体群の処理
DE69329641T2 (de) 1992-03-31 2001-06-21 Abbott Lab Verfahren zur mehrfachen ligase-kettenreaktion
GB9220808D0 (en) * 1992-10-02 1992-11-18 Medical Res Council Antibody genes
US6096878A (en) 1993-05-10 2000-08-01 Japan Tobacco Inc. Human immunoglobulin VH gene segments and DNA fragments containing the same
PT1231268E (pt) 1994-01-31 2005-11-30 Univ Boston Bancos de anticorpos policlonais
FR2724393A1 (fr) 1994-09-12 1996-03-15 Inst Nat Sante Rech Med Obtention d'un anticorps monoclonal recombinant humanise a partir d'un anticorps monoclonal murin, sa production en cellules d'insecte, et ses utilisations
US6111166A (en) 1994-09-19 2000-08-29 Medarex, Incorporated Transgenic mice expressing human Fcα and β receptors
US6258529B1 (en) 1994-12-01 2001-07-10 Oravax, Inc. PCR amplification of rearranged genomic variable regions of immunoglobulin genes
US5882856A (en) 1995-06-07 1999-03-16 Genzyme Corporation Universal primer sequence for multiplex DNA amplification
DE852011T1 (de) * 1995-09-14 2001-10-11 Univ California Für natives prp-sc spezifische antikörper
JP2002514919A (ja) * 1997-04-04 2002-05-21 バイオサイト ダイアグノスティックス,インコーポレイテッド 多価ライブラリーおよびポリクローナルライブラリー
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
WO1999016904A1 (en) * 1997-09-29 1999-04-08 City Of Hope Efficient linking of nucleic acid segments
BR9813365A (pt) 1997-12-05 2004-06-15 Scripps Research Inst Método para produção e humanização de um anticorpo monoclonal de rato
US6194551B1 (en) 1998-04-02 2001-02-27 Genentech, Inc. Polypeptide variants
JP2003516150A (ja) 1999-12-08 2003-05-13 ジェンセット 潜在性分泌タンパク質をコードする全長ヒトcDNA
ATE359819T1 (de) * 2000-05-26 2007-05-15 Symphogen As Rekombinante oder gereinigte polyklonale antikörper zur behandlung den allergien
IL136459A0 (en) 2000-05-30 2001-06-14 Galim Galil Immunology Ltd Antibody library
US6849259B2 (en) 2000-06-16 2005-02-01 Symphogen A/S Polyclonal antibody composition for treating allergy
US6994963B1 (en) 2000-07-10 2006-02-07 Ambion, Inc. Methods for recombinatorial nucleic acid synthesis
US6867021B2 (en) 2001-02-20 2005-03-15 Board Of Trustees Of Michigan State University Multiplex RT-PCR/PCR for simultaneous detection of bovine coronavirus, bovine rotavirus, Cryptosporidium parvum, and Escherichia coli
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
PT1583830E (pt) 2003-01-07 2006-11-30 Symphogen As Método para produzir proteínas policlonais recombinantes
US20060275766A1 (en) 2003-01-07 2006-12-07 Haurum John S Method for manufacturing recombinant polyclonal proteins
US20060228350A1 (en) * 2003-08-18 2006-10-12 Medimmune, Inc. Framework-shuffling of antibodies
ATE474915T1 (de) 2003-11-19 2010-08-15 Us Gov Health & Human Serv Verfahren zur induktion der entwicklung und terminalen differenzierung von gedächtnis-b- zellen
KR101319848B1 (ko) 2004-07-20 2013-10-18 심포젠 에이/에스 재조합 폴리클로날 단백질 또는 폴리클로날 세포주의구조적 특성화 방법
AU2005263331B8 (en) 2004-07-20 2011-06-16 Symphogen A/S Anti-Rhesus D recombinant polyclonal antibody and methods of manufacture
JP2008289483A (ja) * 2007-05-25 2008-12-04 Symphogen As 真核生物系において発現可能な形質転換体のスクリーニング

Also Published As

Publication number Publication date
BRPI0414282A (pt) 2006-11-21
TW200519201A (en) 2005-06-16
EP1921144A2 (en) 2008-05-14
DE602004012299T2 (de) 2009-08-13
PL1670912T3 (pl) 2008-08-29
DE602004012299D1 (de) 2008-04-17
EP1670912B1 (en) 2008-03-05
SI1670912T1 (sl) 2008-08-31
TWI333977B (en) 2010-12-01
PT1921144E (pt) 2012-01-11
US20070141048A1 (en) 2007-06-21
EP1670912A2 (en) 2006-06-21
DK1921144T3 (da) 2012-03-19
ES2375529T3 (es) 2012-03-01
WO2005042774A2 (en) 2005-05-12
JP4651619B2 (ja) 2011-03-16
AU2004286019B2 (en) 2011-04-14
AU2004286019A2 (en) 2005-05-12
CN1856571B (zh) 2011-05-11
WO2005042774A3 (en) 2005-06-09
PL1921144T3 (pl) 2012-05-31
CN102199593A (zh) 2011-09-28
ATE388228T1 (de) 2008-03-15
EP1921144A3 (en) 2009-12-30
DK1670912T3 (da) 2008-06-23
EP1516929A3 (en) 2006-06-07
ES2302542T3 (es) 2008-07-16
CA2539576A1 (en) 2005-05-12
NZ545936A (en) 2009-04-30
EP1921144B1 (en) 2011-12-14
US20100310558A1 (en) 2010-12-09
EP1516929A2 (en) 2005-03-23
JP2007505611A (ja) 2007-03-15
PT1670912E (pt) 2008-04-30
AU2004286019A1 (en) 2005-05-12
CN1856571A (zh) 2006-11-01
MY148907A (en) 2013-06-14
US7749697B2 (en) 2010-07-06
ATE537256T1 (de) 2011-12-15

Similar Documents

Publication Publication Date Title
PL1670912T3 (pl) Sposób łączenia sekwencji
DK1828381T3 (da) Templatedirigeret split-and-mix-syntese af småmolekylebiblioteker
WO2004070352A3 (en) Methods, mixtures, kits and compositions pertaining to analyte determination
DE69940623D1 (de) Prozess zur Synthetisierung von Nukleinsäure
WO2003000841A3 (en) Dye-labeled ribonucleotide triphosphates
BRPI0315652B8 (pt) molécula de ácido nucleico isolada, vetor, polipeptídeo de fusão, e, multímero
DK1608748T3 (da) Ligeringskodning af små molekyler
DE69942701D1 (de) Kontinuierliche in vitro-evolution.
DE602005017042D1 (de) Stellenspezifisches system zur erstellung vielfältiger proteinsequenzen
MY144323A (en) Method for linking sequences of interest
DK1711531T3 (da) Neutraliserende anti-TLR4/-MD-2-antistoffer og fremgangsmåder til anvendelse deraf
FR2825707B1 (fr) Procede de preparation de catalyseurs metalliques a base de carbenes, pour l'hydrosilylation de composes insatures et catalyseurs de ce type
ATE298759T1 (de) Verfahren zur herstellung von 2'-fluoro-beta-l- arabinofuranosylnukleosiden
ATE318279T1 (de) Verfahren zur herstellung von organomodifizierten polysiloxanen unter verwendung ionischer flüssigkeiten
GB9821655D0 (en) Chemical constructs
NO20061373L (no) Fremgangsmate for a linke interessante sekvenser
WO2005042717A3 (en) Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods
DE69933776D1 (de) GABA B-REZEPTOR-SUBTYPEN GABA B-R1c UND GABA B-R2 UND DEREN HETERODIMERE
DE60218533D1 (de) Nukleotidsequenzen mit aktivität zur steuerung der translationseffizienz und deren nutzung